OpalGenix
Indianapolis, Indiana, United States
About OpalGenix
OpalGenix empowers clinicians to personalize therapy to maximize pain relief while minimizing the adverse effects of opioid and pain medications with a genetic signature-based prediction and clinical decision support. OpalGenix empower clinicians to tailor safe and effective patient-centered pain management plans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Grant (Feb 2022)
- Website: opalgenix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital, Medical
Social Profiles
Canonical: https://fsome.com/organization/opalgenix-2512587 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.